Search research articles
Contact Us
Filters
Showing results (111-120 of 127) with videos related to
Page
of 13
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
November 15, 2018
The role of oxaliplatin in the adjuvant setting of different Lauren's type of gastric adenocarcinoma after D2 gastrectomy: a real-world study
Xi Cheng, Shan Yu, Yan Wang, et al.
Journal of the National Cancer Institute
|
August 11, 2019
Role of Asparagine Endopeptidase in Mediating Wild-Type p53 Inactivation of Glioblastoma
Yingying Lin, Keman Liao, Yifeng Miao, et al.
Oncotarget
|
February 11, 2016
Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study
Qingyang Feng, Ye Wei, Li Ren, et al.
The Oncologist
|
June 27, 2019
Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study
Yiyi Yu, Yong Fang, Zhenbin Shen, et al.
Journal of Natural Products
|
January 5, 2022
Targeted Discovery of Amantamide B, an Ion Channel Modulating Nonapeptide from a South China Sea <i>Oscillatoria</i> Cyanobacterium
Te Li, Chuchu Xi, Yiyi Yu, et al.
Cancer Communications (London, England)
|
July 19, 2022
Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
Mengxuan Zhu, Erbao Chen, Shan Yu, et al.
Cell Death & Disease
|
July 13, 2024
IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages
Jiayu Zhang, Yu Dong, Shan Yu, et al.
Nature Communications
|
October 15, 2024
Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial
Jing Wu, Shilong Zhang, Shan Yu, et al.
Nature Communications
|
August 23, 2024
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study
Xiaojing Xu, Luoyan Ai, Keshu Hu, et al.
Oncogenesis
|
September 21, 2022
Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway
Mengling Liu, Xiaojing Xu, Ke Peng, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 127) with videos related to
Sort By:
Page
of 13
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
November 15, 2018
The role of oxaliplatin in the adjuvant setting of different Lauren's type of gastric adenocarcinoma after D2 gastrectomy: a real-world study
Xi Cheng, Shan Yu, Yan Wang, et al.
Journal of the National Cancer Institute
|
August 11, 2019
Role of Asparagine Endopeptidase in Mediating Wild-Type p53 Inactivation of Glioblastoma
Yingying Lin, Keman Liao, Yifeng Miao, et al.
Oncotarget
|
February 11, 2016
Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study
Qingyang Feng, Ye Wei, Li Ren, et al.
The Oncologist
|
June 27, 2019
Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study
Yiyi Yu, Yong Fang, Zhenbin Shen, et al.
Journal of Natural Products
|
January 5, 2022
Targeted Discovery of Amantamide B, an Ion Channel Modulating Nonapeptide from a South China Sea <i>Oscillatoria</i> Cyanobacterium
Te Li, Chuchu Xi, Yiyi Yu, et al.
Cancer Communications (London, England)
|
July 19, 2022
Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
Mengxuan Zhu, Erbao Chen, Shan Yu, et al.
Cell Death & Disease
|
July 13, 2024
IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages
Jiayu Zhang, Yu Dong, Shan Yu, et al.
Nature Communications
|
October 15, 2024
Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial
Jing Wu, Shilong Zhang, Shan Yu, et al.
Nature Communications
|
August 23, 2024
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study
Xiaojing Xu, Luoyan Ai, Keshu Hu, et al.
Oncogenesis
|
September 21, 2022
Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway
Mengling Liu, Xiaojing Xu, Ke Peng, et al.
Page
of 13